India MCA Insolvency Liquidation Filings — June 01, 2026
This intelligence stream covers 14 filings related to India's MCA insolvency and restructuring landscape, with a dominant theme of corporate restructuring through NCLT-approved schemes and ongoing Corporate Insolvency Resolution Processes (CIRPs). A significant cluster involves Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited, which are pursuing a merger with multiple NCLT-convened meetings scheduled for July 2, 2026, indicating a major consolidation in the eye healthcare sector. The CIRP filings for Impex Ferro Tech, PS IT Infrastructure, Future Lifestyle Fashions, and Astron Paper & Board Mill reveal persistent stress, with the latter two showing severe operational shutdowns and auditor disclaimers. A critical outlier is the unrelated financial data for Nectar Lifesciences, which shows a massive 125% YoY widening of net losses to ₹29,288.48 Lakh, driven by discontinued operations. The Triton Valves amalgamation of a loss-making subsidiary into a profitable parent highlights a strategic move to absorb losses, while the Ramco Cements filing is a procedural step in a related-party restructuring. Overall, the filings paint a picture of active corporate restructuring, with a mix of strategic mergers and distressed CIRPs, requiring close monitoring of creditor and shareholder votes.